Literature DB >> 36097109

Functions and clinical applications of exosomes in pancreatic cancer.

Zhichen Jiang1,2, Huiju Wang1,3,4, Yiping Mou1,3,4, Li Li1,3,4, Weiwei Jin5,6,7.   

Abstract

Pancreatic cancer (PC) is one of the most malignant tumors and has an abysmal prognosis, with a 5-year survival rate of only 11%. At present, the main clinical dilemmas in PC are the lack of biomarkers and the unsatisfactory therapeutic effects. The treatments for and outcomes of PC have improved, but remain unsatisfactory. Exosomes are nanosized extracellular vesicles, and an increasing number of studies have found that exosomes play an essential role in tumor pathology. In this review, we describe the process of exosome biogenesis, as well as exosome extraction methods and identification strategies, and we then explain in detail the roles and mechanisms of exosomes in invasion, metastasis, chemoresistance and immunosuppression in PC. Finally, we summarize the clinical applications of exosomes. Our observations indicate that exosomes represent a novel direction in the clinical treatment of PC.
© 2022. The Author(s).

Entities:  

Keywords:  Biomarker; Exosome; Extracellular vesicles; Pancreatic cancer; Therapy

Year:  2022        PMID: 36097109     DOI: 10.1007/s11033-022-07765-8

Source DB:  PubMed          Journal:  Mol Biol Rep        ISSN: 0301-4851            Impact factor:   2.742


  68 in total

Review 1.  Borderline resectable pancreatic cancer. Challenges and controversies.

Authors:  Luis Sabater; Elena Muñoz; Susana Roselló; Dimitri Dorcaratto; Marina Garcés-Albir; Marisol Huerta; Desamparados Roda; María Carmen Gómez-Mateo; Antonio Ferrández-Izquierdo; Antonio Darder; Andrés Cervantes
Journal:  Cancer Treat Rev       Date:  2018-06-13       Impact factor: 12.111

Review 2.  Exosomes.

Authors:  D Michiel Pegtel; Stephen J Gould
Journal:  Annu Rev Biochem       Date:  2019-06-20       Impact factor: 23.643

3.  Projecting cancer incidence and deaths to 2030: the unexpected burden of thyroid, liver, and pancreas cancers in the United States.

Authors:  Lola Rahib; Benjamin D Smith; Rhonda Aizenberg; Allison B Rosenzweig; Julie M Fleshman; Lynn M Matrisian
Journal:  Cancer Res       Date:  2014-06-01       Impact factor: 12.701

4.  Vesicle formation during reticulocyte maturation. Association of plasma membrane activities with released vesicles (exosomes).

Authors:  R M Johnstone; M Adam; J R Hammond; L Orr; C Turbide
Journal:  J Biol Chem       Date:  1987-07-05       Impact factor: 5.157

5.  Whole genomes redefine the mutational landscape of pancreatic cancer.

Authors:  Nicola Waddell; Marina Pajic; Ann-Marie Patch; David K Chang; Karin S Kassahn; Peter Bailey; Amber L Johns; David Miller; Katia Nones; Kelly Quek; Michael C J Quinn; Alan J Robertson; Muhammad Z H Fadlullah; Tim J C Bruxner; Angelika N Christ; Ivon Harliwong; Senel Idrisoglu; Suzanne Manning; Craig Nourse; Ehsan Nourbakhsh; Shivangi Wani; Peter J Wilson; Emma Markham; Nicole Cloonan; Matthew J Anderson; J Lynn Fink; Oliver Holmes; Stephen H Kazakoff; Conrad Leonard; Felicity Newell; Barsha Poudel; Sarah Song; Darrin Taylor; Nick Waddell; Scott Wood; Qinying Xu; Jianmin Wu; Mark Pinese; Mark J Cowley; Hong C Lee; Marc D Jones; Adnan M Nagrial; Jeremy Humphris; Lorraine A Chantrill; Venessa Chin; Angela M Steinmann; Amanda Mawson; Emily S Humphrey; Emily K Colvin; Angela Chou; Christopher J Scarlett; Andreia V Pinho; Marc Giry-Laterriere; Ilse Rooman; Jaswinder S Samra; James G Kench; Jessica A Pettitt; Neil D Merrett; Christopher Toon; Krishna Epari; Nam Q Nguyen; Andrew Barbour; Nikolajs Zeps; Nigel B Jamieson; Janet S Graham; Simone P Niclou; Rolf Bjerkvig; Robert Grützmann; Daniela Aust; Ralph H Hruban; Anirban Maitra; Christine A Iacobuzio-Donahue; Christopher L Wolfgang; Richard A Morgan; Rita T Lawlor; Vincenzo Corbo; Claudio Bassi; Massimo Falconi; Giuseppe Zamboni; Giampaolo Tortora; Margaret A Tempero; Anthony J Gill; James R Eshleman; Christian Pilarsky; Aldo Scarpa; Elizabeth A Musgrove; John V Pearson; Andrew V Biankin; Sean M Grimmond
Journal:  Nature       Date:  2015-02-26       Impact factor: 49.962

Review 6.  Pancreatic ductal adenocarcinoma: State-of-the-art 2017 and new therapeutic strategies.

Authors:  Marta Chiaravalli; Michele Reni; Eileen M O'Reilly
Journal:  Cancer Treat Rev       Date:  2017-08-23       Impact factor: 12.111

Review 7.  The biology and function of exosomes in cancer.

Authors:  Raghu Kalluri
Journal:  J Clin Invest       Date:  2016-04-01       Impact factor: 14.808

Review 8.  Regulation and modulation of antitumor immunity in pancreatic cancer.

Authors:  Joshua Leinwand; George Miller
Journal:  Nat Immunol       Date:  2020-08-17       Impact factor: 25.606

Review 9.  From state-of-the-art treatments to novel therapies for advanced-stage pancreatic cancer.

Authors:  Christopher Nevala-Plagemann; Manuel Hidalgo; Ignacio Garrido-Laguna
Journal:  Nat Rev Clin Oncol       Date:  2019-11-08       Impact factor: 66.675

10.  RAB31 marks and controls an ESCRT-independent exosome pathway.

Authors:  Denghui Wei; Weixiang Zhan; Ying Gao; Liyan Huang; Run Gong; Wen Wang; Ruhua Zhang; Yuanzhong Wu; Song Gao; Tiebang Kang
Journal:  Cell Res       Date:  2020-09-21       Impact factor: 25.617

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.